Global Targeted DNA & RNA Sequencing Market 2023 by Company, Regions, Type and Application, Forecast to 2029

According to our (Global Info Research) latest study, the global Targeted DNA & RNA Sequencing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Targeted DNA & RNA Sequencing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Targeted DNA & RNA Sequencing market size and forecasts, in consumption value ($ Million), 2018-2029
Global Targeted DNA & RNA Sequencing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Targeted DNA & RNA Sequencing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Targeted DNA & RNA Sequencing market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Targeted DNA & RNA Sequencing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Targeted DNA & RNA Sequencing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, Inc., F. Hoffmann-La Roche Ltd, Agilent Technologies, GATC Biotech Ag and Oxford Nanopore Technologies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Targeted DNA & RNA Sequencing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    DNA-based Targeted Sequencing
    RNA-based Targeted Sequencing
Market segment by Application
    Human Biomedical Research
    Plant & Animal Sciences
    Drug Discovery
    Others
Market segment by players, this report covers
    Illumina, Inc.
    F. Hoffmann-La Roche Ltd
    Agilent Technologies
    GATC Biotech Ag
    Oxford Nanopore Technologies
    Thermo Fisher Scientific, Inc.
    DNASTAR Inc.
    QIAGEN
    BGI
    Perkin Elmer, Inc.
    Pacific Biosciences of California, Inc.
    Bio-Rad Laboratories, Inc.
    Integrated DNA Technologies, Inc.
    RainDance Technologies, Inc.
    PierianDx
    Genomatix GmbH
    Macrogen, Inc.
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Targeted DNA & RNA Sequencing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Targeted DNA & RNA Sequencing, with revenue, gross margin and global market share of Targeted DNA & RNA Sequencing from 2018 to 2023.
Chapter 3, the Targeted DNA & RNA Sequencing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Targeted DNA & RNA Sequencing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Targeted DNA & RNA Sequencing.
Chapter 13, to describe Targeted DNA & RNA Sequencing research findings and conclusion.